beta
IA Trial Radar

Mostrando estudos clínicos para Diabetes realizados em: Bélgica.

Posso ajudar você a entender condições de saúde, tratamentos ou encontrar estudos clínicos próximos.
Nossa ferramenta de busca suporta apenas o inglês. Para pesquisa e discussão em outros idiomas, use a IA Trial Radar acima ou selecione filtros de condições médicas e locais abaixo.
41 resultados
 
Condição médica
Diabetes
×
 
Palavras-chave
Monitorização contínua da glicose
×
 
Locais
Bélgica
×
 
Sexo
Todos
×
 
Título do estudo
Status
Continuous Glucose Monitoring for Women with Gestational Diabetes (CORDELIA) NCT06310356
Em recrutamento
Define Predictors for Posttransplant Diabetes Mellitus Study (DECODE) NCT06440330
Em recrutamento
Beta Cell Function in (Pre)Type 1 Diabetes NCT01402037
Desconhecido
To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period (DETECT) NCT06904846
Recrutamento por convite
Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 Diabetes (ALERTT1) NCT03772600
Concluído
Comparison Between Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System and the FreeStyle Libre Flash Glucose Monitoring System NCT03602963
Concluído
Prospective Randomized Clinical Trial Assessing the Short Term Clinical Impact of Continuous vs Flash Glucose Monitoring in Children, Adolescents and Young Adults With Type 1 Diabetes (GluMoCAY) NCT04249102
Desconhecido
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes NCT05777330
Em recrutamento
The GLOW Study - The YANG System NCT04782934
Concluído
Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaemic Control in Type 1 Diabetic Patients? NCT00726440
Concluído
Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec (GLADE) NCT05434559
Concluído
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL (FUTURE-GLARE) NCT05109520
Concluído
Diabeloop for Kids (DBL4K) NCT03671915
Concluído
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1) NCT02268214
ConcluídoResultados publicados
Diabeloop for Teens (DBL4T) NCT04725591
Concluído
Proof of Concept - Identification of Patient-specific Parameters for Bolus Calculators for Type 1 Diabetes (POC-IDENTITY-1) NCT03414320
Concluído
A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice (CONNECT 1) NCT05069545
Concluído
Smart MDI Study (CIP343) NCT06645834
Concluído
24-hour Movement Behaviors in Adults With Type 1 Diabetes (24h-MBs_T1D) NCT06425640
Em recrutamento
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4) NCT04880850
ConcluídoResultados publicados
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec (COMBINE 1) NCT05352815
ConcluídoResultados publicados
Hyperglycemia and (Pre)Diabetes in Pediatric Renal and Liver Transplantation. (DIAB-GRAFT) NCT05464043
Concluído
cArdiopulmonary exerCise Test Assessing Multiple bIOmarkers iN Type 1 Diabetes NCT05097339
Concluído
INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy NCT00790088
ConcluídoResultados publicados
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) NCT02414958
ConcluídoResultados publicados
CGM Boosted by Artificial Intelligence for Better Glycaemic Control in T2 Diabetes (MAGIC-T2D) NCT07064499
Ativo, não recrutando
Cardiac Dysfunction in Adolescents With Type 1 Diabetes: Contribution of Daily-life Glucoregulation and Impact on Cardiorespiratory Exercise Capacity (GIIADMT1) NCT04052919
Concluído
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes (Onset® 5) NCT02825251
ConcluídoResultados publicados
The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects NCT05597605
Concluído
A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus® NCT00391027
ConcluídoResultados publicados
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2) NCT02460978
ConcluídoResultados publicados
Single Dose Escalation Study of PF-05190457 in Healthy Volunteers NCT01247896
Concluído
MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D) (Meld-ATG) NCT04509791
Concluído
A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function NCT04628481
Interrompido
Um estudo para investigar a eficácia e segurança de teplizumab comparado com placebo em participantes de 1 a 25 anos de idade com diabetes tipo 1 estágio 3 (βETA PRESERVE) NCT07088068
Em recrutamento
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes (SAFEGUARD) NCT07187531
Em recrutamento
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes NCT01243424
ConcluídoResultados publicados
Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes (DIABIL-2) NCT02411253
Concluído
Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT) NCT03875729
ConcluídoResultados publicados
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) NCT04524949
Interrompido
Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes (GLUREDIA) NCT06770621
Em recrutamento